Bristol-Myers Squibb Balance Sheet Health
Financial Health criteria checks 3/6
Bristol-Myers Squibb has a total shareholder equity of $17.1B and total debt of $52.4B, which brings its debt-to-equity ratio to 306.9%. Its total assets and total liabilities are $94.6B and $77.6B respectively. Bristol-Myers Squibb's EBIT is $9.0B making its interest coverage ratio 8.8. It has cash and short-term investments of $6.7B.
Key information
306.9%
Debt to equity ratio
US$52.39b
Debt
Interest coverage ratio | 8.8x |
Cash | US$6.65b |
Equity | US$17.07b |
Total liabilities | US$77.58b |
Total assets | US$94.65b |
Recent financial health updates
Recent updates
Bristol-Myers Squibb: A High-Yield Bargain With Growth On The Horizon
Oct 06Bristol-Myers Squibb: Cobenfy Approval A Major Coup For The Dealmaker (Upgrade)
Sep 27Bristol-Myers Still A Value Play Despite Appreciating 26.56% From 2024 Lows
Sep 06Bristol-Myers Squibb Company's (NYSE:BMY) Share Price Is Matching Sentiment Around Its Revenues
Aug 15Bristol-Myers Squibb: A Potential Comeback In Healthcare
Aug 06Bristol-Myers Squibb: Q2 Earnings Look Like An Inflection Point
Jul 27Bristol Myers Squibb: The More It Drops, The More I Buy
Jul 16Is Bristol-Myers Squibb (NYSE:BMY) A Risky Investment?
Jun 13Bristol Myers: Quality Fundamentals Suppressed By Interest Rates
Jun 09Bristol-Myers Squibb: Looking Beyond The One-Time Quarterly Loss
Jun 03Bristol-Myers Squibb: 5.5% Yielder Has Been Crushed In What Could Be A Generational Buying Opportunity
May 23Bristol-Myers Squibb: A Lost Decade?
May 03Lacklustre Performance Is Driving Bristol-Myers Squibb Company's (NYSE:BMY) Low P/S
Apr 29Is Bristol Myers Squibb A Buy At These Bottom Levels?
Apr 22Bristol Myers Squibb: Seriously Undervalued At Peak Pessimism (Rating Upgrade)
Apr 12Bristol-Myers Squibb Is A Speculative Buy On Price Action (Technical Analysis)
Apr 02Bristol-Myers Squibb (NYSE:BMY) Is Due To Pay A Dividend Of $0.60
Mar 21Bristol-Myers Squibb Is Not A Buy For Me
Mar 19Bristol-Myers Squibb: Compelling Value From The New Products Portfolio And 4.5% Yield
Mar 07Bristol-Myers Squibb (NYSE:BMY) Is Due To Pay A Dividend Of $0.60
Mar 07We Think Bristol-Myers Squibb's (NYSE:BMY) Healthy Earnings Might Be Conservative
Feb 20Bristol-Myers Squibb Company (NYSE:BMY) Just Released Its Annual Results And Analysts Are Updating Their Estimates
Feb 06Bristol-Myers Squibb: Massive Discount Spells Opportunity
Feb 04Financial Position Analysis
Short Term Liabilities: BMY's short term assets ($26.9B) exceed its short term liabilities ($23.3B).
Long Term Liabilities: BMY's short term assets ($26.9B) do not cover its long term liabilities ($54.3B).
Debt to Equity History and Analysis
Debt Level: BMY's net debt to equity ratio (267.9%) is considered high.
Reducing Debt: BMY's debt to equity ratio has increased from 156.1% to 306.9% over the past 5 years.
Debt Coverage: BMY's debt is well covered by operating cash flow (27%).
Interest Coverage: BMY's interest payments on its debt are well covered by EBIT (8.8x coverage).